iSpecimen Inc.
For the period ended Dec 31, 2025. Filed Apr 1, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 1, 2026
ISPC$0.74-6.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2025 and 2024
Balance Sheets
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $6,880,835 | $1,878,408 |
| Accounts receivable and other receivables, net of allowance for doubtful accounts of $646,067 and $620,433 at December 31, 2025 and 2024, respectively | 48,298 | 1,444,636 |
| Inventory | — | 45,110 |
| Prepaid expenses and other current assets | 25,457 | 219,782 |
| Total current assets | 6,954,590 | 3,587,936 |
| Property and equipment, net | 25,543 | 93,563 |
| Internally developed software, net | 1,270,017 | 4,611,954 |
| Intangible assets under development | 1,000,000 | — |
| Other intangible assets, net | — | 716,700 |
| Operating lease right-of-use asset | 269,160 | 327,977 |
| Security deposits | 12,100 | 12,100 |
| Total assets | $9,531,410 | $9,350,230 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $5,362,604 | $4,197,561 |
| Accrued expenses | 619,242 | 1,168,786 |
| Operating lease current obligation | 56,925 | 43,369 |
| Deferred revenue | 192,535 | 360,708 |
| Total current liabilities | 6,231,306 | 5,770,424 |
| Operating lease long-term obligation | 211,873 | 268,798 |
| Total liabilities | 6,443,179 | 6,039,222 |
| Commitments and contingencies (See Note 9) | ||
| Stockholders’ equity | ||
| Common stock, $0.0001 par value, 200,000,000 shares authorized, 8,480,147 issued and 8,478,597 outstanding at December 31, 2025 and 1,698,454 issued and 1,696,904 outstanding at December 31, 2024 | 848 | 170 |
| Series C convertible preferred stock, $0.0001 par value 50,000,000 shares authorized, 6,875 issued and outstanding at December 31, 2025 and Nil issued and outstanding as at December 31, 2024 | 1 | — |
| Additional paid-in capital | 85,437,703 | 75,173,627 |
| Treasury stock, 1,550 shares at December 31, 2025 and 2024, at cost | (172) | (172) |
| Accumulated other comprehensive income | — | — |
| Accumulated deficit | (82,350,149) | (71,862,617) |
| Total stockholders’ equity | 3,088,231 | 3,311,008 |
| Total liabilities and stockholders’ equity | $9,531,410 | $9,350,230 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.